U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Nucleic Acid
Created
by admin
on Wed Apr 02 17:11:02 GMT 2025
Edited
by admin
on Wed Apr 02 17:11:02 GMT 2025
Nucleic Acid Type mRNA VACCINE
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
3E9P89C6JX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CX-040631
Preferred Name English
Vintesomeran
INN  
Official Name English
CX-040631 Omicron (XBB.1.16)
Common Name English
messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S)glycoprotein (Omicron variant XBB.1.16; bas
Common Name English
CX-040631 (COVID-19 Omicron variant XBB.1.16)
Common Name English
vintesomeran [INN]
Common Name English
RNA (recombinant 5?-(m7G-(5??5?)-ppp-Gm)-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 pre-fusion spike glycoprotein [982-proline,983-proline] XBB.1.16 variant plus 5?- and 3?-untranslated flanking
Common Name English
Code System Code Type Description
SMS_ID
300000051179
Created by admin on Wed Apr 02 17:11:02 GMT 2025 , Edited by admin on Wed Apr 02 17:11:02 GMT 2025
PRIMARY
FDA UNII
3E9P89C6JX
Created by admin on Wed Apr 02 17:11:02 GMT 2025 , Edited by admin on Wed Apr 02 17:11:02 GMT 2025
PRIMARY
NCI_THESAURUS
C203096
Created by admin on Wed Apr 02 17:11:02 GMT 2025 , Edited by admin on Wed Apr 02 17:11:02 GMT 2025
PRIMARY
CAS
2923391-66-4
Created by admin on Wed Apr 02 17:11:02 GMT 2025 , Edited by admin on Wed Apr 02 17:11:02 GMT 2025
PRIMARY
INN
13098
Created by admin on Wed Apr 02 17:11:02 GMT 2025 , Edited by admin on Wed Apr 02 17:11:02 GMT 2025
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_4098 4098 / 4098
Linkage Site Range Site Count
Phosphate 1_2-1_4098 4097 / 4097
Related Record Type Details
CX-040631 expressed protein antigen
EXPRESSED PROTEIN->VECTOR
SARS-COV2
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
Vintesomeran
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOTIDE SUBSTITUTION [1_1] 5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE T0HQY09X7B
NUCLEOSIDE_SUBSTITUTION U N1-METHYLPSEUDOURIDINE 09RAD4M6WF
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966